Does Rallies show 13F holders for LH?

Yes. Rallies tracks hedge fund and 13F ownership data for LH, including fund names, share counts, latest tracked quarter, and position changes when available.

Is LH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LH. It does not provide personalized investment advice.

LH (Labcorp Holdings Inc.) Stock Analysis - Hedge Fund Holdings

Labcorp Holdings Inc. (LH) is a publicly traded Healthcare sector company. As of May 20, 2026, LH trades at $254.87 with a market cap of $20.96B and a P/E ratio of 22.31. LH moved +0.39% today. Year to date, LH is +0.81%; over the trailing twelve months it is +1.56%. Its 52-week range spans $209.38 to $293.72. Analyst consensus is strong buy with an average price target of $310.78. Rallies surfaces LH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns LH stock?

Hedge funds tracked by Rallies that own LH include Pinebridge Investments, Bridgewater Associates, Maverick Capital, Panagora Asset, and Chilton Investment. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Labcorp Holdings Inc..

LH Key Metrics

Key financial metrics for LH
Metric	Value
Price	$254.87
Market Cap	$20.96B
P/E Ratio	22.31
EPS	$11.36
Dividend Yield	0.72%
52-Week High	$293.72
52-Week Low	$209.38
Volume	135.35K
Avg Volume	0
Revenue (TTM)	$14.14B
Net Income	$942.70M
Gross Margin	28.83%

Top Hedge Funds Holding LH

Pinebridge Investments holds 49.13K shares of LH, changed -77.13% as of Sep 30, 2024.
Bridgewater Associates holds 11.18K shares of LH, changed -35.60% as of Mar 31, 2026.
Maverick Capital holds 1.60K shares of LH, changed -90.91% as of Mar 31, 2026.
Panagora Asset holds 1.28K shares of LH, changed +0.00% as of Mar 31, 2026.
Chilton Investment holds 1.17K shares of LH, changed +0.26% as of Mar 31, 2026.

Latest LH News

Labcorp Unveils MyLabcorp AI App for Lab Results, Trend Tracking and Scheduling — May 20, 2026
Labcorp surges after Q1 beat and higher 2026 EPS guidance — Apr 30, 2026
Labcorp Q1 Revenue Up 5.8% to $3.54B, Lifts Full-Year EPS Guidance — Apr 30, 2026
Labcorp slides ahead of April 30 earnings as traders de-risk positions — Apr 23, 2026
Labcorp Launches FDA-Approved PD-L1 Test for Keytruda in Ovarian Cancer — Apr 22, 2026

Recent LH Insider Trades

Schechter Adam H sold 5.90K (~$1.50M) on May 11, 2026.
Wilkinson Peter J sold 1.63K (~$436.09K) on Mar 27, 2026.
Meltzer Jonathan C sold 839 (~$224.05K) on Mar 27, 2026.

LH Analyst Consensus

10 analysts cover LH: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $310.78.

Common questions about LH

Who owns LH stock?: Hedge funds tracked by Rallies that own LH include Pinebridge Investments, Bridgewater Associates, Maverick Capital, Panagora Asset, and Chilton Investment. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Labcorp Holdings Inc..
Does Rallies show 13F holders for LH?: Yes. Rallies tracks hedge fund and 13F ownership data for LH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is LH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LH. It does not provide personalized investment advice.